Kenneth R. Foster

Kenneth R. Foster is Professor Emeritus of Bioengineering at the University of Pennsylvania, where he has maintained a distinguished career in biomedical engineering and technology policy. He is Associate Professor in the Department of Bioengineering at the University of Pennsylvania, with research interests spanning radiofrequency exposure safety, medical device regulation, and the ethical implications of emerging technologies.

Foster's contribution to deception detection research lies in his critical analysis of emerging neurotechnology-based lie detection methods. His 2005 paper with Paul Root Wolpe and Daniel Langleben focused on the technical limitations of developing brain-based lie detection technology, noting that measurement validity of the new technologies remains largely unknown. The paper examined issues of personal privacy, forensic application, measurement validity, psychological paradigms, lack of standardization, and vulnerability to countermeasures. This work became a foundational reference in the field of neuroethics and forensic neuroimaging.

Foster's 2005 work with Wolpe and Langleben became influential enough that it was appraised and revisited five years later, demonstrating its lasting impact on policy discussions surrounding fMRI-based lie detection. He was among the first scholars to elaborate that comprehensive understanding of new technologies' error rates requires not only within-subject accuracy but also consideration of false positives, constitutional implications, and privacy concerns. His interdisciplinary collaboration bridged engineering, bioethics, and neuroscience perspectives on credibility assessment technology.

Foster's broader research portfolio focuses primarily on the biological effects of electromagnetic fields, radiofrequency safety standards, and technology policy rather than deception detection specifically. His involvement in lie detection research represents an extension of his longstanding interest in the ethical and regulatory dimensions of emerging biomedical technologies, particularly those with potential homeland security and forensic applications.